Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine

Clinical trial NCT01951677 · COMPLETED

Trial details

NCT number: NCT01951677
Sponsor: Vaxine Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Exposure to Hepatitis B Virus

Start date: 2013-07-01
Primary completion: 2017-10-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.